The global demand for Human Reproductive Technologies Market is presumed to reach the market size of nearly USD XX MN by 2030 from USD XX MN in 2022 with a CAGR of 4% under the study period 2023 - 2030.
Human reproductive technologies (HRT) encompass a range of medical and scientific techniques and procedures designed to assist individuals or couples with fertility issues in achieving pregnancy and childbirth. These technologies are used when natural conception is challenging or not possible due to various factors, such as infertility, reproductive health disorders, or personal circumstances.
Rising infertility rates due to lifestyle changes and medical conditions have fueled demand for assisted reproductive technologies like IVF and ICSI. Technological advancements have improved success rates and reduced risks. Growing awareness of fertility treatment options and changing social norms, including delayed childbearing and diverse family structures, contribute to the market's growth. Medical conditions, fertility preservation needs, and the desires of the LGBTQ+ community also drive demand. Globalization and medical tourism play a role, along with evolving regulations and legal frameworks. The emotional impact of infertility, success stories, and evolving societal attitudes all contribute to the complex landscape of human reproductive technologies.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of human reproductive technologies. The growth and trends of human reproductive technologies industry provide a holistic approach to this study.
This section of the human reproductive technologies market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Reproductive Technology
By Gender
This section covers the regional outlook, which accentuates current and future demand for the Human Reproductive Technologies market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Human Reproductive Technologies market include CooperSurgical, Inc., Teva Pharmaceutical Industries, AbbVie Inc., Ferring B.V., Merck KGaA, Genea Limited, Ivftech, Bayer AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . HUMAN REPRODUCTIVE TECHNOLOGIES – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 Market Attractiveness Analysis By Reproductive Technology
3.7.2 Market Attractiveness Analysis By Gender
3.7.3 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET ANALYSIS BY REPRODUCTIVE TECHNOLOGY
5.1 Overview by Reproductive Technology
5.2 Historical and Forecast Data
5.3 Analysis by Reproductive Technology
5.4 Infertility Treatment (Drugs (Follitropin Alfa, Follitropin Beta, Menotropins, Others), Devices (Sperm Separation Devices, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulator Systems, Others) Historic and Forecast Sales by Regions
5.5 Contraceptive (Drugs (Oral Contraceptives, Topical Contraceptives, Contraceptive Injectable), Devices (Condoms, IUD, Cervical Caps, Diaphragms, Others) Historic and Forecast Sales by Regions
6 . GLOBAL HUMAN REPRODUCTIVE TECHNOLOGIES MARKET ANALYSIS BY GENDER
6.1 Overview by Gender
6.2 Historical and Forecast Data
6.3 Analysis by Ge ...